title: [Induction of cervix ripening with hydrophilic Dilapan rods in pregnancy at term].
abstract: During the period between July 1, 1993 and July 31, 1994 the authors preinduced 52 pregnant women in term using the cervical dilatator Dilapan. The group comprised patients with single pregnancies > 38 weeks, vertex presentation, cervical score < 5 and reactive NST. They introduced into the cervical canal 4 Dilapan rods for 12-18 hours and after extraction of the rods, depending on the finding, the patients were induced with Prostaglandin e.a. or oxytocin i.v. The preinduction was successful in 46 patients (88.5 per cent), in 16 patients (30.8 per cent) uterine contractions were induced by Dilapan alone. Forceps delivery was performed 4 times (7.7 per cent) and Caesarean section 12 times (23.1 per cent). Apart from pain in the hypograstrium resembling menstruation pain, no side-effects were recorded. There were no irregularities such as the length of labour stages, blood loss due to injury during labour and the incidence of neonatal hypoxia. Based on the described experience Dilapan can be recommended as a preinduction method for maturation of the portio uteri.
authors.affiliation: II. Universitäts-Frauenklinik, Masaryk Universität Brno.
authors.forename: A
authors.initials: A
authors.lastname: Roztocil
authors.forename: J
authors.initials: J
authors.lastname: Miklica
authors.forename: M
authors.initials: M
authors.lastname: Koudelka
authors.forename: J
authors.initials: J
authors.lastname: Jelínek
authors.forename: S
authors.initials: S
authors.lastname: Kutálková
authors.forename: T
authors.initials: T
authors.lastname: Burnog
authors.forename: L
authors.initials: L
authors.lastname: Pilka
mesh_terms: D000328:Adult; D002585:Cesarean Section; D015232:Dinoprostone / Q000008:administration & dosage; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D007751:Labor, Induced / Q000379:methods*; D009772:Obstetrical Forceps; D010121:Oxytocin / Q000008:administration & dosage; D011108:Polymers; D011247:Pregnancy; D018566:Pregnancy, High-Risk; D016896:Treatment Outcome
chemical_list: D011108:Polymers; C077755:dilapan; D010121:Oxytocin; D015232:Dinoprostone